The familial hypertrophic cardiomyopathy‐associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils
Open Access
- 31 July 2008
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 586 (15) , 3639-3644
Abstract
The R403Q mutation in β‐myosin heavy chain was the first mutation to be identified as responsible for familial hypertrophic cardiomyopathy (FHC). In spite of extensive work on the functional sequelae of this mutation, the mechanism by which the mutant protein causes the disease has not been definitely identified. Here we directly compare contraction and relaxation mechanics of single myofibrils from left ventricular samples of one patient carrying the R403Q mutation to those from a healthy control heart. Tension generation and relaxation following sudden increase and decrease in [Ca2+] were much faster in the R403Q myofibrils with relaxation rates being the most affected parameters. The results show that the R403Q mutation leads to an apparent gain of protein function but a greater energetic cost of tension generation. Increased energy cost of tension generation may be central to the FHC disease process, help explain some unresolved clinical observations, and carry significant therapeutic implications.Keywords
This publication has 21 references indexed in Scilit:
- Impact of temperature on cross‐bridge cycling kinetics in rat myocardiumThe Journal of Physiology, 2007
- Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic propertiesJournal of Molecular and Cellular Cardiology, 2004
- Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletionTrends in Genetics, 2003
- A transgenic rabbit model for human hypertrophic cardiomyopathyJournal of Clinical Investigation, 1999
- Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1998
- Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome.Journal of Clinical Investigation, 1996
- A Mouse Model of Familial Hypertrophic CardiomyopathyScience, 1996
- Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1995
- Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1993
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationCell, 1990